Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis
Authors:
- 21 May 2024
- journal article
- research article
- Published by Taylor & Francis in Computer Methods in Biomechanics and Biomedical Engineering
- Vol. 28 (13) , 2049-2063
Abstract
PDA is an aggressive cancer with a 5-year survival rate, which is very low. There is no effective prognosis or therapy for PDA because of the lack of target biomarkers. The objective of this article is to identify the target biomarkers for PDA using a bioinformatics approach. In this work, we have analysed the three microarray datasets from the NCBI GEO database. We used the Geo2R tool to analyse the microarray data with the Benjamini and Hochberg false discovery rate method, and the significance level cut-off was set to 0.05. We have identified 659 DEGs from the datasets. There are a total of 15 hub genes that were selected from the PPI network constructed using the STRING application. Furthermore, these 15 genes were evaluated on PDA patients using TCGA and GTEx databases in (GEPIA). The online tool DAVID was used to analyse the functional annotation information for the DEGs. The functional pathway enrichment was performed on the GO and KEGG. The hub genes were mainly enriched for cell division, chromosome segregation, protein binding and microtubule binding. Further, the gene alteration study was performed using the cBioportal tool and screened out six hub genes (ASPM, CENPF, BIRC5, TTK, DLGAP5, and TOP2A) with a high alteration rate in PDA samples. Furthermore, Kaplan-Meier survival analysis was performed on the six hub genes and identified poor-survival outcomes that may be involved in tumorigenesis and PDA development. So, this study concludes that, these six hub genes may be potential prognostic biomarkers for PDA.Keywords
This publication has 41 references indexed in Scilit:
- CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axisStrahlentherapie und Onkologie, 2022
- Integrated bioinformatics analysis of potential biomarkers for pancreatic cancerJournal of Clinical Laboratory Analysis, 2022
- UALCAN: An update to the integrated cancer data analysis platformNeoplasia, 2022
- Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinomaInternational Immunopharmacology, 2021
- Visualizing and interpreting cancer genomics data via the Xena platformNature Biotechnology, 2020
- Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysisJournal of Cellular Biochemistry, 2019
- High NUSAP1 expression predicts poor prognosis in colon cancerPathology - Research and Practice, 2018
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating AktCancer Cell, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Cdk1/Erk2- and Plk1-Dependent Phosphorylation of a Centrosome Protein, Cep55, Is Required for Its Recruitment to Midbody and CytokinesisDevelopmental Cell, 2005